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PreviewsQuorum sensing is a type of bacterial cell-
cell communication that involves the accu-
mulation and detection of secreted mole-
cules known as autoinducers (Waters and 
Bassler, 2005). Quorum sensing was first 
discovered in the bioluminescent marine 
bacterium Vibrio ficheri, which secretes 
the autoinducer acyl-homoserine lactone. 
At high cell densities, the accumulation of 
the autoinducer is sensed by the receptor 
LuxR, which activates target genes, lead-
ing to the production of luciferase. Since 
this early discovery, quorum sensing has 
been found in many other bacteria, and 
the chemical nature and num-
ber of known bacterial auto-
inducers continues to grow. 
For example, the Gram-neg-
ative bioluminescent bacteria 
Vibrio harveyi, which is closely 
related to V. ficheri, also uses 
quorum sensing to control its 
luciferase bioluminescence. It 
does so by integrating infor-
mation from three separate 
autoinducers (AIs): AI-1 (acyl-
homoserine lactones), AI-2 
[(2S,4S)-2-methyl-2,3,3,4-
hydroxybutanoyl homoser-
ine lactone], and CAI-1 [(S)-
3-hydroxytridecan-4-one]. 
Interestingly, V. harveyi uses a 
receptor to sense and respond 
to AI-1, called LuxN, that is not 
homologous to the V. ficheri 
system but instead is more 
closely related to the bacterial 
chemotaxis receptor family 
of membrane-bound sensory 
kinases. In work presented in 
this issue, Swem et al. (2008) dissect the 
function of the LuxN receptor by deter-
mining several residues that are impor-
tant for the binding of the receptor to AI-1 
or a small-molecule antagonist that they 
discovered. They also report mutations 
that affect the balance between the “on” 
and “off” state of the receptor indepen-
dent of ligand (Figure 1).
LuxN is one of the three membrane-
bound receptors mediating quorum 
sensing in V. harveyi. In the “on” state, 
LuxN is a kinase that autophosphory-
lates, leading to a signaling cascade 
that culminates in the degradation of 
LuxR mRNA and an absence of biolu-
minescence (the dark phenotype). With 
autoinducer bound, however, the LuxN 
receptor is biased toward a phosphatase 
activity that ultimately leads to the accu-
mulation of LuxR and a bioluminescent 
phenotype.
Given that the LuxN receptor is mem-
brane bound, has no known three-dimen-
sional structure (other than its predicted 
membrane topology), and is at the top of 
a cascade involving several other pro-
teins and small RNAs, the authors chose 
to explore the effects of site-
specific changes to the recep-
tor in vivo. Their first step was 
to determine the functional 
regions of LuxN by screening 
large libraries of mutations in 
the presence of AI-1 for the 
dark phenotype. They also 
performed a screen for small 
molecules that antagonize 
the effect of AI-1 (molecules 
that cause the dark pheno-
type in the presence of AI-1). 
Identifying these mutants and 
small molecules was just the 
beginning of the characteriza-
tion of LuxN, because each 
mutation resulting in the dark 
phenotype can have many 
mechanistic interpretations. 
For instance, a dark pheno-
type could result from biasing 
the activity of the receptor in 
the AI-1 bound state, interfer-
ing with AI-1 binding, or even 
disrupting the transduction of 
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Quorum sensing plays a key role in the behavior of many bacteria and is carried out by a wide 
diversity of secreted molecules and their receptors. In this issue, Swem et al. (2008) provide 
a detailed site-specific analysis of the functioning of the quorum-sensing receptor LuxN from 
Vibrio harveyi.
Figure 1. LuxN Residues Implicated in the Response to AI-1
The schematic depicts the quorum-sensing receptor LuxN with its predicted 
topology consisting of nine transmembrane helices. Periplasmic loops are 
designated P1–P4, and cytoplasmic loops are designated C1–C4. The ap-
proximate locations of mutations that have a negative effect on AI-1 binding 
and/or signaling (conferring a dark phenotype) are indicated in red. Mutations 
that increased sensitivity to AI-1 are shown in blue. The mutation found to 
interfere with the binding of the antagonist C450-0730 is shown in green.390 Cell 134, August 8, 2008 ©2008 Elsevier Inc.
the signal to the downstream parts of the 
signaling pathway. In the case of small-
molecule antagonists the case is equally 
complex, with possible explanations of 
a dark phenotype including allosteric 
inhibition of transduction, competition 
with AI-1 binding, and binding-induced 
changes in the balance between kinase 
and phosphatase activities.
In order to test the specific roles of 
these mutants and chemical com-
pounds, the authors collected dose-
response curves in which the biolu-
minescent response was measured 
with increasing concentrations of AI-1. 
These dose-response curves were col-
lected for 30 mutants that passed the 
original screen of more than 30,000 
mutants and for several of the mutants 
that suppressed the activity of the 
antagonist C450-0730. A kinetic model 
for the bioluminescent response (the 
eventual readout of the receptor) as a 
function of the concentration of agonist 
and antagonist was used to decipher 
specific kinetic/thermodynamic roles 
from these dose-response curves:
where pon is the percentage of maximal 
luminescent response, and f is the free-
energy difference between the on and 
off states of the receptor in units of kBT 
(where kB is the Boltzmann constant, 
which relates energy to an absolute tem-
perature T). The equation used to model f as a function of binding and dissocia-
tion constants for AI-1 and the antago-
nist C450-0730 is as follows:
where ∆ε is the free-energy gap between 
the “on” and “off” states. With this 
kinetic model in hand, the authors show 
that they can adjust the kinetic param-
eters associated with mutant receptors 
to “collapse” (or fit) the dose-response 
curve of the mutant onto the wild-type 
curve. For example, for some mutants, 
the simplest way to reconcile the dose-
response curve with the wild-type recep-
tor is to adjust the ∆ε parameter, whereas 
for others, adjusting the dissociation 
constant KAI-1off / K
AI-1
on was the most 
parsimonious way of getting the mutant 
curve to agree with the wild-type curve. 
This allowed the authors to determine, 
for example, that several of the mutants 
with dark phenotypes affected the affin-
ity of LuxN for AI-1, whereas other muta-
tions (such as F163A) biased the recep-
tor toward the “on” state independently 
of AI-1 binding affinity. Using this math-
ematical model, they were also able to 
separate mutations that suppressed 
antagonism by C450-0730 into two cat-
egories: those that increased AI-1 bind-
ing affinity (S184N, R245L, G271D) and 
those that interfered with C450-0730 Cell 1binding (I209F). Finally, the effects of 
these suppressor mutants were shown 
to be roughly additive and epistatic to 
mutations that interfere with AI-1 binding 
or bias the receptor to the “on” state. For 
example, they showed that the mutation 
F163A, which required 378-fold more 
AI-1 to switch to phosphatase activity 
than the wild-type receptor, was effec-
tively reversed by engineering a pro-
tein with the four suppressor mutations 
simultaneously. Thus, the kinetic param-
eters discovered by this method stood 
the ultimate test, that of being used to 
design new receptors with a phenotype 
matching site-specific predictions.
Although there is still much to learn 
about LuxN, its downstream pathway, 
and variations on this system found in 
other bacteria, this study is an exquisitely 
complete work that provides explicit 
functional information about LuxN at 
amino acid resolution. Moreover, the 
work represents a useful general strat-
egy for combining in vivo genetic screens 
with chemical biology and mathematical 
modeling. Integrating these techniques 
provides unambiguous information for 
a receptor that could otherwise prove 
challenging to work with in the lab.
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